FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
Romeo Papazyan(Johns Hopkins University), Mark A. Young(Intercept Pharmaceuticals (United States)), Ronald D. Lewis(Intercept Pharmaceuticals (United States)), Emily M. Plummer(Scripps Research Institute), Jingwen Liu(Second Affiliated Hospital of Zhejiang University), Xueqing Liu(Duke-NUS Medical School), Jonathan D. Roth(Rutgers, The State University of New Jersey), Bin Dong(Dalian Minzu University)
Cited by 67
Related Papers
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
|Nature|2011|701
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
|Proceedings of the National Academy of Sciences|2008|433
Hepatic Stearoyl-CoA Desaturase-1 Deficiency Protects Mice from Carbohydrate-Induced Adiposity and Hepatic Steatosis
|Cell Metabolism|2007|433
Amylin: Pharmacology, Physiology, and Clinical Potential
|Pharmacological Reviews|2015|395
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
|American Journal of Physiology-Gastrointestinal and Liver Physiology|2013|294